Skip to main content
. 2016 Sep 24;8(2):3581–3590. doi: 10.18632/oncotarget.12240

Table 1. Baseline characteristics of the patients.

Characteristic (n = 15) Median (range) or total number (%)
Age 73 (54 - 81)
ECOG
0 5 (33%)
1 5 (33%)
2 5 (33%)
Gleason sum
7 1 (7%)
8 1 (7%)
9-10 13 (87%)
Sites of metastases
Bone 14 (93%)
Lymph node 12 (80%)
Liver 3 (20%)
Other 2 (13%)
Lung 1 (7%)
Mean pain intensity score at baseline (0-10)
0 5 (33%)
1-5 8 (53%)
6-10 2 (13%)
Biochemical values
Lactate dehydrogenase (U/L) 287 (167 - 1220)
Hemoglobin (g/dL) 12.3 (8.3 - 15.5)
Total alkaline phosphatase (U/L) 147 (49 - 420)
PSA (μg/L) 388 (3.2 - 10661)
No. of prior hormonal therapies
1 1 (7%)
2 4 (27%)
3 7 (47%)
≥4 3 (20%)
No. of prior chemotherapy regimens
0 5 (33%)
1 5 (33%)
≥2 5 (33%)
Prior 223Ra 5 (33%)
Prior EBRT 9 (60%)

Abbreviations: ECOG, Eastern Cooperative Oncology Group Performance Status; EBRT, External Beam Radiation Therapy.